ROY SMITH: Open Payments
NPI 1245287291 · YREKA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$325 in 10 payments from 5 companies in 2025. Trend: 2023 $85 · 2024 $126 · 2025 $325
Food & beverage: $325
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $152 |
| Braeburn Inc. | 1 | $119 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: BRIXADI, Wegovy, Rybelsus, Ozempic, GVOKE HYPOPEN, MAVYRET, REXULTI.
Industry payments across CA — which companies pay providers there.
